Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -13.76-27.84-15.3241.0512.11

What is the latest EBIT Growth ratio of SUVEN PHARMACEUTICALS ?

The latest EBIT Growth ratio of SUVEN PHARMACEUTICALS is -13.76 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-13.76
Mar2024-27.84
Mar2023-15.32
Mar202241.05
Mar202112.11

How is EBIT Growth of SUVEN PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -13.76
Negative
Mar2024 -27.84
Negative
Mar2023 -15.32
Negative
Mar2022 41.05
238.98
Mar2021 12.11 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹11,835.7 Cr -0.7% 6% -72% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,150.0 Cr -0.9% -3.9% 1.3% Stock Analytics
DIVIS LABORATORIES ₹156,129.0 Cr -0.4% -7.6% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,312.0 Cr -2% -7.5% 27.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,445.2 Cr -1.5% -9.3% 3.8% Stock Analytics
CIPLA ₹98,210.2 Cr 1.7% -8.3% -16.8% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-0.7%

6%

-72%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses